Close

More on ATHA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-331.6% Growth)
- Ratings (5.0 Score)

Upcoming Events

- Earnings (5/9/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Athira Pharma Inc. (NQ:ATHA)
Delayed: 2.01 -0.03 (1.47%)
Prev. Close $2.04  
Open$2.07 
52 Wk High$ 
52 Wk Low$ 
Day High$2.10 
Day Low$2.00 
P/E N/A  
EPS$ 
Volume79,151 

Friends, Peers and Foes (?): AHNR (more...)

Apr 16, 2024 04:37 PM Form 4 Athira Pharma, Inc. For: Apr 15 Filed by: San Martin Javier
Apr 16, 2024 04:35 PM Form 3 Athira Pharma, Inc. For: Apr 15 Filed by: San Martin Javier
Apr 15, 2024 07:02 AM Athira Pharma Inc. (ATHA) Appoints Javier San Martin as Chief Medical Officer
Apr 15, 2024 07:00 AM Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Apr 11, 2024 07:00 AM Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Apr 9, 2024 08:36 AM Form ARS Athira Pharma, Inc. For: Dec 31
Apr 9, 2024 08:34 AM Form DEFA14A Athira Pharma, Inc.
Apr 9, 2024 08:33 AM Form DEF 14A Athira Pharma, Inc. For: May 23
Apr 3, 2024 07:00 AM Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Mar 29, 2024 06:13 AM Form 10-K ATHENA GOLD CORP For: Dec 31
View All Articles

Entities mentioned with ATHA

View All Entities